Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Background & Introduction.

Slides:



Advertisements
Similar presentations
European Centre for Disease Prevention and Control
Advertisements

Developments from the National Quality Board: A New Objective for MRSA Derek Butler Registered Charity No
ACT 52 - Healthcare-Associated Infections
Meeting the Challenge of Mandatory HAI Reporting Marcy Maxwell RN, BSN, CIC Dignity Health March 6, 2012.
Completing Ward List (Form A) & determining eligible patients for PPS PPS Data Collector Training April 2012 Presentation 2.
Information for Action Point Prevalence Survey of Healthcare associated infection and antimicrobial use 26 th June 2012 Dafydd Williams.
Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.
Costs.
CDC Winnable Battles: Preventing Healthcare-Associated Infections (HAIs) National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
Healthcare-associated Infections and Antibiotic Resistance
Healthcare-associated infections & antimicrobial use in long-term care facilities (HALT) 2013 Training Day: Lecture 1 Welcome & Introduction to HALT 2013.
Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre & Beaumont Hospital, Dublin, Ireland HPSC, SARI and National HCAI.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Briefing on 4th Meeting of Antimicrobial Resistance National Focal Points Ljubljana (Slovenia), 13 March 2008 Dominique L. Monnet Senior Expert, Antimicrobial.
Katherine Allen-Bridson, RN, BSN, MScPH, CIC, Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases.
The epidemiology of HAI Scotland Dr Jacqui Reilly Consultant Epidemiologist Head of HAI and IC Group.
A pilot assessment of the impact and resource implications of a 48-hour ward-based stewardship team review on antibiotic use in a tertiary centre Nicola.
Indiana Healthcare Associated Infection Initiative Kickoff.
CDI Prevention in Long Term Care Collaborative Welcome and Project Overview Deborah Quetti RN, MBA, BSN, CPHQ April 9, 2014.
Moving forward together infection prevention and control and AMR Rose Gallagher Nurse Advisor Infection Prevention and Control Royal College of Nursing.
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
Cleanliness Champions: Evaluation of impact on HAI in NHSScotland Professor Jacqui Reilly HPS.
Methodological challenges for AMR surveillance programmes Gous AGS, Pochee E School of Pharmacy Medical University of Southern Africa.
PREPARING FOR PARTICIPATION IN HALT-2 LECTURE 6. To outline the steps necessary to prepare successfully for the HALT 2013 PPS. LECTURE OBJECTIVES.
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset.
Outlines At the completion of this lecture the student will be able to identify the concept and related terms of: Infection- Infection control-
EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015
ECDC Point prevalence survey of healthcare- associated infections and antimicrobial use in acute care hospitals Forms V4.2.
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
Chapter Legislative Representatives Government Affairs Update April 2014.
Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.
EARS-Net data on antimicrobial resistance in Ireland Quarter st March 2016.
CDC Winnable Battles: Preventing Healthcare-Associated Infections (HAIs) National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
Healthcare-associated infections & antimicrobial use in long-term care facilities (HALT) 2016 Training Day: Lecture 1 Welcome & Introduction to HALT 2016.
NOSOCOMIAL INFECTIons (HOSPITAL ACQUIRED INFECTIONS) by lovella d
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
Healthcare-Associated Infection (HAI) and the Role of Diagnostic Testing 1 Date, time, presenter etc. goes here For external use © 2014 Alere. All rights.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
Jean B. Patel, PhD, D(ABMM) Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Disease Centers for Disease Control.
1 Infectious Diseases in the Nursing Home Setting: Challenges and Opportunities for Clinical Investigation 감염내과 R2 김대호 / Prof. 이미숙 Manisha Juthani-Mehta.
Yousef I. Aljeesh, PhD, RN Said Abusalem, PhD, RN Naeem Alkariri, MSN, RN John A. Myers, PhD, MSPH Fawwaz Alaloul, PhD, RN Staff Developed IP Program Increases.
1 Healthcare Associated Infections & Antimicrobial Consumption in Long-Term Care Facilities. (HALT) Mags Moran & Mary Rooney Community Infection Control.
The AHRQ Safety Program for Improving Antibiotic Use
ECDC Point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals Forms V4.2.
PPS Data Collector Training April 2017
Antibiotics: handle with care!
Kelley Garner, MPH MLS(ASCP)CM
AHRQ Safety Program for Improving Antibiotic Use
The AHRQ Safety Program for Improving Antibiotic Use
HELP US TO PREVENT INFECTIONS SPREADING
Professor Alan Johnson Department of HCAI & AMR
Results of the STRUTI project
AHRQ Safety Program for Improving Antibiotic Use
The AHRQ Safety Program for Improving Antibiotic Use
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
Local organisation of the ECDC PPS
HAI January 24, 2018.
Housekeeping.
Interpretation of local, national and European level results
CNISP & CIHI MRSA infection rate comparison Preliminary results
ECDC point prevalence survey (PPS)
Hospital Antibiotic Stewardship Programs
Sources of data (HCAI) Dr Wendy Harrison
Point prevalence survey epidemiology
To Dip Or Not To Dip – Improving the management of Urinary Tract Infection in older people Improving Patient Safety & Care 6th Feb 2019 Continuous Learning,
National Center for Emerging and Zoonotic Infectious Diseases
Tony Crockford & Muhammad Sartaj.
Point prevalence survey (PPS) of healthcare associated infections (HAI) & antimicrobial use (AMU) in acute care Mark McConaghy, Dr Muhammad Sartaj,
EARS-Net results 2011 Ole Heuer
Presentation transcript:

Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Background & Introduction to PPS Presentation 1

Schedule Registration Welcome Objectives Background & introduction to the ECDC PPS Completing the Ward List & deciding patient eligibility – Coffee break Hospital-acquired infection case definitions & case studies – Lunch

Schedule Antimicrobial use & case studies Review of the Patient Forms (Form C) Data entry Review of the Hospital Form (Form B) External validation, Summary, Evaluation – Close

Course Objectives Participants will understand and apply the methodology of the 2012 ECDC Point Prevalence Survey (PPS) of Hospital-Acquired Infections (HAI) & Antimicrobial Use Participants will be able to apply the definitions of antimicrobial use Participants will be able to apply the HAI case definitions

What is a PPS? A prevalence survey provides data at one particular point in time ‘snapshot’ Prevalence = numerator / denominator Numerator = number of patients on the ward who have an active HAI at the time of the survey Denominator = All eligible patients present on the ward at 8am on the day of the survey for that ward

What is a PPS? PPS team visits a ward at 11am on 10/5/12 There were 29 patients present on the ward at 8am The PPS team decides that 26 patients are eligible for inclusion in the PPS – Two have since been transferred to other wards and one has been discharged home After completing the PPS for the ward, 9 patients were identified as receiving systemic antimicrobials Prevalence of antimicrobial use on the ward = 9/26 x 100 = 34.6%

What is a PPS? After completing the PPS for the ward, 4 patients were identified as having active HAI HAI prevalence on the ward = 4/26 x 100 = 15.3%

Hospital Infection Society 2006 PPS UK & Ireland Ireland, Northern Ireland, England & Wales conducted a PPS of healthcare-associated infections (HCAI) in 2006 US Centers for Disease Control & Prevention (CDC) definitions of infection used Infections acquired in another hospital were excluded Only two questions regarding antibiotic use – Systemic antibiotic use ‘Y/N’ – IV antibiotic use ‘Y/N’

Hospital Infection Society 2006 PPS: Ireland 44 acute hospitals (88%) participated in 2006 PPS 7,541 patients surveyed 369 patients with HCAI HCAI prevalence 4.9% Systemic antibiotic use prevalence 34.2%

What’s been happening in Ireland since 2006?

C. difficile infection (CDI) May 2008: National guidance document issued and new cases of CDI became notifiable August 2009: Enhanced CDI surveillance scheme established – All cases of CDI new and recurrent reportable to enhanced surveillance. 37 acute hospitals participating in enhanced surveillance by Q – National quarterly report issued – Quarterly report issued to each participating hospital

Source: HPSC

C. difficile subcommittee reconvened October 2011 to revise national guidelines

S. aureus invasive infection Captured via EARS-Net – 40 laboratories participated in 2011 S. aureus BSI via enhanced surveillance scheme – 16 laboratories participated in 2011 – 2011 results in preparation – 2010: 23% of SAB due to infected CVC & 6% due to infected PVC Source: HPSC

Total number of S. aureus (MRSA and MSSA) bloodstream isolates and proportion (%) MRSA from acute hospitals (public & private) by year, 2004 to 2011Q3 †Data for 2011 provisional to the end of Q3 only Source: HPSC

2005 MRSA guidelines have just been updated and will be published shortly

Source: HPSC

Total number of E. faecium (VREfm and VSEfm) bloodstream isolates, and VREfm proportions from acute hospitals (public & private) by year, 2004 to 2011 VREfm, Vancomycin-resistant E. faecium; VSEfm, Vancomycin-susceptible E. faecium †Data for 2011 provisional to the end of Q3 only Source: HPSC

CRE Carbapenem resistant Enterobacteriaceae Multi-drug resistant Gram-negative organisms Extremely limited antimicrobial treatment options First reported case in Ireland in 2009 In 2011, CRE reported from 36 patients in 8 hospitals around Ireland – majority of cases reported from outbreaks Four hospitals reported CRE outbreaks in 2011 CRE infection is notifiable to public health National guidelines on the prevention & control of multi-drug resistant organisms (other than MRSA) will be published shortly

Period 1 = June 2011 Period 2 = October 2011 Source: HPSC

Aims of this PPS To conduct a PPS of HAI & antimicrobial use across all EU Member States during using a common protocol To estimate the total burden of HAI & antimicrobial use within: – EU – Each Member State – Each participating healthcare facility – By specialty type – By patient type

26 Overview of previous European PPS: Mean HAI prevalence 7% 21 documented PPS in European countries over past 15 years

Aims of this PPS To share the results of the PPS with those who need to know: – Local – Regional – National – International – EU To use the data generated within YOUR hospital to help YOU and your colleagues to: – Identify priority areas for future targeted HAI surveillance – Identify interventions to prevent HAI – Identify areas for targeting antimicrobial stewardship

Preliminary PPS data: submitted to ECDC at 28/2/12 Most common HAI types reported from participating hospitals to date: 1.Pneumonia 2.Surgical site infection 3.Urinary tract infection 4.Bloodstream infection 5.Gastrointestinal infection 6.Systemic infections 7.Skin & soft tissue infection 8.All other infection types Preliminary data only - for information

Preliminary PPS data: submitted to ECDC at 28/2/12 Over half of all HAI episodes associated with positive microbiology results HAI causative microorganisms: – Enterobacteriaceae – Gram-positive cocci – Other Gram-negative bacilli – Fungi Preliminary data only - for information

Summary Last PPS performed in Ireland six years ago – 44 acute hospitals, 7,521 patients surveyed – 34.2% on antibiotics – 4.9% HCAI Many interim developments to raise awareness of HAI & need for prudent antimicrobial use 2012 PPS provides us with the opportunity to see where we are now and to direct our future interventions for ongoing improvement

Any Questions?

Overview of data to be collected during PPS Nursing & Midwifery staff PPS team leader PPS team assisted by staff caring for patients

Ward List (Form A)

Hospital Form (Form B)

Patient Form (Form C)

Three pages Five sections – Section 1 – Patient details – Section 2 – Risk factors – Section 3 – Condition of interest – Antimicrobial use Y/N and HAI Y/N – Section 4 – Antimicrobial use data – Section 5 – HAI data Sections 1, 2, 3 completed for EVERY eligible patient 100%

Patient Form (Form C) Three pages Five sections – Section 1 – Patient details – Section 2 – Risk factors – Section 3 – Condition of interest – Antimicrobial use Y/N and HAI Y/N – Section 4 – Antimicrobial use data – Section 5 – HAI data Sections 1, 2, 3 & 4 completed for EVERY eligible patient receiving systemic antimicrobials ~ 33%

Patient Form (Form C) Three pages Five sections – Section 1 – Patient details – Section 2 – Risk factors – Section 3 – Condition of interest – Antimicrobial use and HAI – Section 4 – Antimicrobial use data – Section 5 – HAI data Sections 1, 2, 3, 4 & 5 completed for EVERY eligible patient receiving systemic antimicrobials with an active HAI ~ 5%

Your hospital.... TOTAL NUMBER OF PAPER FORMS TO BE COMPLETED* 150 ACUTE BEDS DIVIDED INTO 8 WARDS 300 ACUTE BEDS DIVIDED INTO 12 WARDS 600 ACUTE BEDS DIVIDED INTO 22 WARDS Ward Forms (Form A) Hospital Form (Form B) 111 Patient Forms (Form C) Form C Section 1, 2, Form C Section 1, 2, 3 & Form C Section 1,2, 3, 4 & *The completed paper versions of one Form B & all Form Cs are used to enter your hospital’s PPS data onto secure ‘web-based’ data entry system

Patient Form (Form C)

There is space on Form C to record up to five systemic antimicrobial prescriptions AND up to three different hospital-acquired infections

Patient Form (Form C)

The answers to 10/12 (83%) questions in Section 1 & 2 can be directly transcribed from the completed Ward List. For each eligible patient, the PPS team will need to decide:  Admitting consultant’s specialty  Underlying disease prognosis

Patient Form (Form C)  ‘Patient on antimicrobials’ answered on Ward List  Also check Ward List to identify patients who have undergone surgery in the last 24 hours to pick up surgical prophylaxis

Patient Form (Form C)

Any Questions?